Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04656184
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2020-11-30
Brief Title:
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin IVIG Retreatment in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Sponsor:
Organization:
Assistance Publique - Hôpitaux de Paris
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
84
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: